The patent ductus arteriosus management debate: it's not over yet.
作者信息
Lopata Susan M, Slaughter James C, Gillam-Krakauer Maria, Reese Jeff
机构信息
Departments of Pediatrics, Vanderbilt University School of Medicine and the Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, TN, USA.
Biostatistics, Vanderbilt University School of Medicine and the Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, TN, USA.
出版信息
J Perinatol. 2021 May;41(5):923-925. doi: 10.1038/s41372-021-01059-w. Epub 2021 Apr 15.
Abstract
摘要
相似文献
1
The patent ductus arteriosus management debate: it's not over yet.动脉导管未闭的治疗争论：尚未结束。
J Perinatol. 2021 May;41(5):923-925. doi: 10.1038/s41372-021-01059-w. Epub 2021 Apr 15.
2
Effect of fetal lung maturation on the treatment of patent ductus arteriosus in premature infants.胎儿肺成熟度对早产儿动脉导管未闭治疗的影响。
Minerva Pediatr (Torino). 2023 Feb;75(1):148-150. doi: 10.23736/S2724-5276.22.06985-3. Epub 2022 Sep 23.
3
PD(AI): the role of artificial intelligence in the management of patent ductus arteriosus.动脉导管未闭（AI）：人工智能在动脉导管未闭管理中的作用
J Perinatol. 2023 Feb;43(2):257-258. doi: 10.1038/s41372-023-01606-7. Epub 2023 Jan 16.
4
Management of Patent Ductus Arteriosus: Are We Looking at the Right Outcomes?动脉导管未闭的管理：我们关注的结果正确吗？
J Pediatr. 2017 Mar;182:10-11. doi: 10.1016/j.jpeds.2016.12.033. Epub 2016 Dec 29.
5
Indomethacin patent ductus arteriosus prophylaxis in the modern era: renal implications.现代时代吲哚美辛预防动脉导管未闭：对肾脏的影响
J Perinatol. 2023 Aug;43(8):1045-1046. doi: 10.1038/s41372-023-01681-w. Epub 2023 Apr 21.
6
[Research progress on auxiliary indexes and methods of diagnosis and treatment of patent ductus arteriosus in preterm].[早产儿动脉导管未闭诊疗辅助指标及方法的研究进展]
Zhonghua Er Ke Za Zhi. 2024 Mar 25;62(4):381-384. doi: 10.3760/cma.j.cn112140-20231216-00432.
7
Impact of patent ductus arteriosus and subsequent therapy with indomethacin on cerebral oxygenation in preterm infants.动脉导管未闭及随后使用吲哚美辛治疗对早产儿脑氧合的影响。
Pediatrics. 2008 Jan;121(1):142-7. doi: 10.1542/peds.2007-0925.
8
Toward a Rational Approach to Patent Ductus Arteriosus Trials: Selecting the Population of Interest.迈向动脉导管未闭试验的合理方法：选择目标人群。
J Pediatr. 2021 Jun;233:11-13. doi: 10.1016/j.jpeds.2021.01.012. Epub 2021 Jan 10.
9
Patent ductus arteriosus in the neonate.新生儿动脉导管未闭
Pediatr Clin North Am. 1986 Jun;33(3):545-60. doi: 10.1016/s0031-3955(16)36042-4.
10
Letter to the editor: Treatment of patent ductus arteriosus in premature infants.致编辑的信：早产儿动脉导管未闭的治疗
J Perinatol. 2018 Jul;38(7):944. doi: 10.1038/s41372-018-0085-z. Epub 2018 Mar 7.
本文引用的文献
1
Patent ductus arteriosus shunt elimination results in a reduction in adverse outcomes: a post hoc analysis of the PDA RCT cohort.动脉导管未闭分流消除导致不良结局减少：PDA RCT 队列的事后分析。
J Perinatol. 2021 May;41(5):1134-1141. doi: 10.1038/s41372-021-01002-z. Epub 2021 Mar 8.
2
A Pilot Randomized Controlled Trial of Early Targeted Patent Ductus Arteriosus Treatment Using a Risk Based Severity Score (The PDA RCT).一项基于风险严重程度评分的早期目标性动脉导管未闭治疗的随机对照试验（PDA RCT）。
J Pediatr. 2021 Feb;229:127-133. doi: 10.1016/j.jpeds.2020.10.024. Epub 2020 Oct 16.
3
Does crossover treatment of control subjects invalidate results of randomized trials of patent ductus arteriosus treatment?对照治疗的交叉设计是否会使动脉导管未闭治疗的随机试验结果无效？
J Perinatol. 2020 Dec;40(12):1863-1870. doi: 10.1038/s41372-020-00848-z. Epub 2020 Oct 6.
4
Defining "Haemodynamic Significance" of the Patent Ductus Arteriosus: Do We Have All the Answers?动脉导管未闭的血流动力学意义定义：我们是否已经有了所有的答案？
Neonatology. 2020;117(2):225-232. doi: 10.1159/000506988. Epub 2020 May 25.
5
Duration of significant patent ductus arteriosus and bronchopulmonary dysplasia in extremely preterm infants.极早产儿持续性动脉导管未闭与支气管肺发育不良的关系
J Perinatol. 2019 Dec;39(12):1648-1655. doi: 10.1038/s41372-019-0496-5. Epub 2019 Sep 25.
6
Prevention of Bronchopulmonary Dysplasia: A Summary of Evidence-Based Strategies.支气管肺发育不良的预防：循证策略总结
Neoreviews. 2019 Apr;20(4):e189-e201. doi: 10.1542/neo.20-4-e189.
7
Lack of Equipoise in the PDA-TOLERATE Trial: A Comparison of Eligible Infants Enrolled in the Trial and Those Treated Outside the Trial.PDA-TOLERATE 试验中的均衡缺失：比较试验中入组的合格婴儿与试验外治疗的婴儿。
J Pediatr. 2019 Oct;213:222-226.e2. doi: 10.1016/j.jpeds.2019.05.049. Epub 2019 Jun 27.
8
PDA: To treat or not to treat.动脉导管未闭：治疗还是不治疗。
Congenit Heart Dis. 2019 Jan;14(1):46-51. doi: 10.1111/chd.12708.
9
PDA-TOLERATE Trial: An Exploratory Randomized Controlled Trial of Treatment of Moderate-to-Large Patent Ductus Arteriosus at 1 Week of Age.PDA-TOLERATE 试验：一项在出生后 1 周时治疗中至大的动脉导管未闭的探索性随机对照试验。
J Pediatr. 2019 Feb;205:41-48.e6. doi: 10.1016/j.jpeds.2018.09.012. Epub 2018 Oct 16.
10
Non-pharmacological management of a hemodynamically significant patent ductus arteriosus.动脉导管未闭的非药物治疗。
Semin Fetal Neonatal Med. 2018 Aug;23(4):245-249. doi: 10.1016/j.siny.2018.03.008. Epub 2018 Mar 16.
Zotero 插件